CN101843673B - Chinese medicament for treating arteriosclerosis - Google Patents
Chinese medicament for treating arteriosclerosis Download PDFInfo
- Publication number
- CN101843673B CN101843673B CN2009102371128A CN200910237112A CN101843673B CN 101843673 B CN101843673 B CN 101843673B CN 2009102371128 A CN2009102371128 A CN 2009102371128A CN 200910237112 A CN200910237112 A CN 200910237112A CN 101843673 B CN101843673 B CN 101843673B
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- chinese
- radix
- fine powder
- chinese medicament
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a Chinese medicament for treating arteriosclerosis and belongs to the field of Chinese medicaments for treating cardio-cerebral-vascular system diseases. The invention aims to provide the Chinese medicament with good effect and quick response. The Chinese medicament is prepared from the following raw materials: sandalwood, Chinese angelica, radix pseudo-ginseng, white paeony root and lucid ganoderma. The Chinese medicament has the effects of strengthening body resistance and banking up root, tonifying qi and nourishing blood, activating blood and dissolving stasis and softening blood vessels, and has the advantages of obvious effect, exact medicinal effect and quick response.
Description
Technical field
The invention belongs to the field of Chinese medicines of treatment diseases of cardiovascular and cerebrovascular systems.
Background technology
Existingly be used for the treatment of arteriosclerotic Chinese medicine, there are some distinct issues: be exactly that therapeutic effect is obvious inadequately, it is slower to take effect, so that many arteriosclerotics wish to take good care of treatment for a long time with Chinese medicine, and can not find definite effect, Chinese medicine evident in efficacy, have dissatisfied to this patient more.
At problem set forth above, the invention provides the arteriosclerotic Chinese medicine of a kind of treatment, it can solve, and this type of Chinese medicine effect was obvious inadequately in the past, the slower problem that takes effect, effective, instant effect, it is remarkable to have effect, and drug effect is definite, the advantage of quick result.
Summary of the invention
The present invention is achieved through the following technical solutions:
1, the arteriosclerotic Chinese medicine of a kind of treatment adopts the raw material of Chinese medicine preparation, and filling a prescription is (by weight):
Lignum Santali Albi 4-30 part Radix Angelicae Sinensis 4-30 part Radix Notoginseng 3-20 part
Radix Paeoniae Alba 4-30 part Ganoderma 2-12 part
The arteriosclerotic Chinese medicine of this treatment is made by following method:
(1) by above-mentioned weight ratio, Lignum Santali Albi, Radix Angelicae Sinensis, the Radix Paeoniae Alba are extracted through conventional water extraction process, make the extractum fine powder;
(2) by above-mentioned weight ratio, Radix Notoginseng, Ganoderma are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder; As required, can be made into Chinese medicine electuary, granule, powder, capsule, watered pill, tablets and other formulations.
The present invention is according to the folk tradition prescription, and the theory according to traditional Chinese medical science the body resistance strengthening and constitution consolidating, blood circulation promoting and blood stasis dispelling develops meticulously.Ganoderma, Radix Paeoniae Alba the body resistance strengthening and constitution consolidating in the side, benefiting QI and nourishing blood, tranquilizing by nourishing the heart, enhancing human body immunity power; Radix Angelicae Sinensis, Radix Notoginseng nourshing blood and promoting blood circulation blood stasis dispelling, Ganoderma, the Radix Paeoniae Alba and Radix Angelicae Sinensis, Radix Notoginseng compatibility, the prosperous hemapodium of gas helps blood circulation and vessel softening; Be aided with the Lignum Santali Albi eliminating turbid pathogen with aromatics, the logical cold expelling of temperature.All medicine compatibilities bring out the best in each other, and play the body resistance strengthening and constitution consolidating altogether, benefiting QI and nourishing blood, and blood circulation promoting and blood stasis dispelling, the merit of vessel softening, effective, instant effect, it is remarkable to have effect, and drug effect is definite, the advantage of quick result.
The specific embodiment
By following embodiment the present invention is done and to specify:
1, get following prescription (weight is unit by gram):
Lignum Santali Albi 80 gram Radix Angelicae Sinensis 80 gram Radix Notoginseng 60 grams
The Radix Paeoniae Alba 80 kairine sesames 40 grams
Weight in accordance with regulations, with conventional water extraction process Lignum Santali Albi, Radix Angelicae Sinensis, the Radix Paeoniae Alba are extracted, make extractum fine powder 72 grams, Radix Notoginseng, Ganoderma are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder, make fine particle, the capsule of packing into No. 0 is made 614 of Chinese medicinal capsules, and every capsules includes Chinese medicine fine powder and extract 0.28 gram.
2, get following prescription (weight is unit by gram):
Lignum Santali Albi 160 gram Radix Angelicae Sinensis 160 gram Radix Notoginseng 90 grams
The Radix Paeoniae Alba 160 kairine sesames 60 grams
By above-mentioned same method, make 1050 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
3, get following prescription (weight is unit by gram):
Lignum Santali Albi 300 gram Radix Angelicae Sinensis 300 gram Radix Notoginseng 200 grams
The Radix Paeoniae Alba 300 kairine sesames 120 grams
By above-mentioned same method, make 2107 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
4, get following prescription (by weight):
6 parts of 8 portions of Radix Notoginseng of 8 parts of Radix Angelicae Sinensis of Lignum Santali Albi
4 parts of 8 portions of Ganodermas of the Radix Paeoniae Alba
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
5, get following prescription (by weight):
15 parts of 20 portions of Radix Notoginseng of 20 parts of Radix Angelicae Sinensis of Lignum Santali Albi
8 parts of 20 portions of Ganodermas of the Radix Paeoniae Alba
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
Clinical data:
The present invention is an example with traditional Chinese medical science arteriosclerosis, through 7 routine clinical observations.Selecting tcm diagnosis arteriosclerosis is standard: have a delicate constitution, limb is soft weak, and nervous, cardiopalmus, gas are tight, and the rhythm of the heart increases to about 120 times/minute, dizziness and blurred vision, and it is not good enough to sleep, and extremity are numb, myocardial ischemia.As above symptom can be made a definite diagnosis.In making a definite diagnosis the object of observation, male's 4 examples, women's 3 examples do not have other serious disease, and the age is 42 years old-79 years old, 66.4 years old mean age.
Efficacy determination:
1, produce effects: body constitution strengthens, and on one's body energetically, nervous, cardiopalmus, gas are tight, tachycardia, and numb limbs and tense tendons, myocardial ischemia, it is not good enough to sleep etc., and symptom is obviously alleviated.
2, effective: body constitution strengthens, and nervous, cardiopalmus, gas are tight, and symptoms such as numbness are alleviated to some extent.
3, invalid: the disease no change.
During clinical experiment, withdraw other medicines and health nutrient.Taking Chinese medicinal capsule of the present invention, observed 3 months, is a course of treatment.Instructions of taking: every day 2 times, each 4 capsules, every capsules include Chinese medicine fine powder and extract 0.28 gram, warm water delivery service after meal, symptom promptly has alleviation after 30 days, take 3 months after, symptom is obviously improved.7 philtrums of clinical experiment, produce effects 3 people, effective 3 people, invalid 1 people, total effective rate 85.7%.
Claims (1)
1. the arteriosclerotic Chinese medicine of treatment is characterized in that, described Chinese medicine is to adopt the raw material of Chinese medicine preparation, and the weight proportion of raw material of Chinese medicine is:
Lignum Santali Albi 4---20 parts of 30 parts of Radix Angelicae Sinensis 4---30 portions of Radix Notoginseng 3---
12 parts of the Radix Paeoniae Albas 4---30 portions of Ganodermas 2---
The arteriosclerotic Chinese medicine of this treatment is made by following method:
(1) by above-mentioned weight ratio, Lignum Santali Albi, Radix Angelicae Sinensis, the Radix Paeoniae Alba are extracted through conventional water extraction process, make the extractum fine powder;
(2) by above-mentioned weight ratio, Radix Notoginseng, Ganoderma are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder; Make Chinese medicine granules, capsule, watered pill, Tabules.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009102371128A CN101843673B (en) | 2009-11-04 | 2009-11-04 | Chinese medicament for treating arteriosclerosis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009102371128A CN101843673B (en) | 2009-11-04 | 2009-11-04 | Chinese medicament for treating arteriosclerosis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101843673A CN101843673A (en) | 2010-09-29 |
| CN101843673B true CN101843673B (en) | 2011-07-20 |
Family
ID=42768609
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2009102371128A Expired - Fee Related CN101843673B (en) | 2009-11-04 | 2009-11-04 | Chinese medicament for treating arteriosclerosis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101843673B (en) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1287006A (en) * | 1999-09-08 | 2001-03-14 | 王化忠 | Chinese medicine powder for treating hypertension and arteriosclerosis |
-
2009
- 2009-11-04 CN CN2009102371128A patent/CN101843673B/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1287006A (en) * | 1999-09-08 | 2001-03-14 | 王化忠 | Chinese medicine powder for treating hypertension and arteriosclerosis |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101843673A (en) | 2010-09-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101843661B (en) | Chinese medicament for treating angina | |
| CN101843804A (en) | Chinese medicament for treating benign prostatic hyperplasiabrain | |
| CN101843660B (en) | Chinese medicament for treating tachycardia | |
| CN101843712B (en) | Chinese medicament for treating angina | |
| CN101850015B (en) | Chinese medicament for treating arteriosclerosis | |
| CN101843673B (en) | Chinese medicament for treating arteriosclerosis | |
| CN101843672B (en) | Chinese medicament for treating arteriosclerosis | |
| CN101843753B (en) | Chinese medicament for treating angina | |
| CN101843644B (en) | Chinese medicament for treating tachycardia | |
| CN101850055B (en) | Chinese medicament for treating coronary heart diseases | |
| CN101843717B (en) | Chinese medicament for treating coronary disease | |
| CN101843755A (en) | Chinese medicament for treating diabetic cardiopathy | |
| CN101843679B (en) | Chinese medicament for treating cervical spondylosis | |
| CN101843693A (en) | Chinese medicament for treating diabetic nephropathy | |
| CN101843793B (en) | Chinese medicament for treating tachycardia | |
| CN101843758B (en) | Chinese medicament for treating coronary disease | |
| CN101843645B (en) | Chinese medicament for treating tachycardia | |
| CN101843835B (en) | Chinese medicament for treating coronary diseases | |
| CN101849985B (en) | Chinese medicament for treating tachycardia | |
| CN101843832B (en) | Chinese medicament for treating coronary disease | |
| CN101843647B (en) | Chinese medicament for treating angina | |
| CN101843720B (en) | Chinese medicament for treating angina | |
| CN101850034B (en) | Chinese medicament for treating angina | |
| CN101843782A (en) | Chinese medicament for treating arteriosclerosis | |
| CN101850033A (en) | Chinese medicament for treating arteriosclerosis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: RUGAO JUNZHANG ELECTRONICS CO., LTD. Free format text: FORMER OWNER: BEIJING LVYUANQIUZHENG TECHNOLOGY DEVELOPMENT CO., LTD. Effective date: 20130809 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 100040 SHIJINGSHAN, BEIJING TO: 226500 NANTONG, JIANGSU PROVINCE |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20130809 Address after: Zhu Yao Cun Bai Pu Zhen 226500 Jiangsu city of Rugao Province in 18 groups Patentee after: Rugao Jun Zhang Electronics Co., Ltd. Address before: 100040 Beijing city Shijingshan District street Babaoshan Lugu Village District No. 7 building 10-602 room Patentee before: Beijing Lvyuanqiuzheng Technology Development Co., Ltd. |
|
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110720 Termination date: 20171104 |